Tls Beta Pte. Ltd. - Net Worth and Insider Trading
Tls Beta Pte. Ltd. Net Worth
The estimated net worth of Tls Beta Pte. Ltd. is at least $2.3 Billion dollars as of 2024-06-06. Tls Beta Pte. Ltd. is the 2101 Beneficial owner of Innovent Biologics Inc and owns about 64,482,850 shares of Innovent Biologics Inc (HKSE:01801) stock worth over $2.3 Billion. Details can be seen in Tls Beta Pte. Ltd.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tls Beta Pte. Ltd. has not made any transactions after 2018-10-31 and currently still holds the listed stock(s).
Transaction Summary of Tls Beta Pte. Ltd.
Tls Beta Pte. Ltd. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tls Beta Pte. Ltd. owns 1 companies in total, including Innovent Biologics Inc (HKSE:01801) .
Click here to see the complete history of Tls Beta Pte. Ltd.’s form 4 insider trades.
Insider Ownership Summary of Tls Beta Pte. Ltd.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:01801 | Innovent Biologics Inc | 2018-10-31 | 2101 Beneficial owner |
Tls Beta Pte. Ltd. Latest Holdings Summary
Tls Beta Pte. Ltd. currently owns a total of 1 stock. Tls Beta Pte. Ltd. owns 64,482,850 shares of Innovent Biologics Inc (HKSE:01801) as of October 31, 2018, with a value of $2.3 Billion.
Latest Holdings of Tls Beta Pte. Ltd.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:01801 | Innovent Biologics Inc | 2018-10-31 | 64,482,850 | 35.75 | 2,305,261,888 |
Holding Weightings of Tls Beta Pte. Ltd.
Tls Beta Pte. Ltd. Form 4 Trading Tracker
According to the SEC Form 4 filings, Tls Beta Pte. Ltd. has made a total of 0 transactions in Innovent Biologics Inc (HKSE:01801) over the past 5 years. The most-recent trade in Innovent Biologics Inc is the sale of 0 shares on October 31, 2018, which brought Tls Beta Pte. Ltd. around $0.
Insider Trading History of Tls Beta Pte. Ltd.
- 1
Tls Beta Pte. Ltd. Trading Performance
Tls Beta Pte. Ltd. Ownership Network
Tls Beta Pte. Ltd. Owned Company Details
What does Innovent Biologics Inc do?
Who are the key executives at Innovent Biologics Inc?
Tls Beta Pte. Ltd. is the 2101 Beneficial owner of Innovent Biologics Inc. Other key executives at Innovent Biologics Inc include 2502 Approved lending agent JPMorgan Chase & Co. , 2101 Beneficial owner Yu De-chao Michael , and Temasek Holdings (private) Limited .
Innovent Biologics Inc (HKSE:01801) Insider Trades Summary
Over the past 18 months, Tls Beta Pte. Ltd. made no insider transaction in Innovent Biologics Inc (HKSE:01801). Other recent insider transactions involving Innovent Biologics Inc (HKSE:01801) include a net purchase of 488,776 shares made by The Capital Group Companies, Inc. , a net sale of 0 shares made by Morgan Stanley , and a net sale of 1,409,211 shares made by Yu De-chao Michael .
In summary, during the past 3 months, insiders sold 906,250 shares of Innovent Biologics Inc (HKSE:01801) in total and bought 0 shares, with a net sale of 906,250 shares. During the past 18 months, 10,350,711 shares of Innovent Biologics Inc (HKSE:01801) were sold and 9,696,776 shares were bought by its insiders, resulting in a net sale of 653,935 shares.
Innovent Biologics Inc (HKSE:01801)'s detailed insider trading history can be found in Insider Trading Tracker table.
Innovent Biologics Inc Insider Transactions
Tls Beta Pte. Ltd. Mailing Address
Above is the net worth, insider trading, and ownership report for Tls Beta Pte. Ltd.. Currently GuruFocus does not have mailing address information for Tls Beta Pte. Ltd..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
